Open-Label, Randomized, Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers
Condition: Human Gastrointestinal Physiology Data Interventions: Drug: Glucotrol XL 5Mg Extended-Release Tablet; Drug: Glipizide ER 5 MG 24 HR Extended Release Oral Tablet; Drug: Rifaximin 200Mg Tab; Drug: 13C6-Glipizide Sponsors: University of Michigan; Food and Drug Administration (FDA) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials